Tailored Therapy in Hodgkin Lymphoma, Based on Predefined Risk Factors and Early Interim PET/CT: Israeli H2 StudyEldad J. Dann, Ora Paltiel, Rachel Bar‐Shalom et al.|Blood|2014Cited by 4